Fuentes-Martín R, Ayuda-Durán P, Hanes R, Gallego-Yerga L, Wolterinck L, Enserink JM, Álvarez R, Peláez R(2024) Promising anti-proliferative indolic benzenesulfonamides alter mechanisms with sulfonamide nitrogen substituents Eur J Med Chem, 275, 116617 DOI 10.1016/j.ejmech.2024.116617, PubMed 38959729
Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S(2024) CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia Cell Rep Med, 5(6), 101572 DOI 10.1016/j.xcrm.2024.101572, PubMed 38754420
Wu C, Gunnarsson EB, Myklebust EM, Köhn-Luque A, Tadele DS, Enserink JM, Frigessi A, Foo J, Leder K(2024) Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data PLoS Comput Biol, 20(3), e1011888 DOI 10.1371/journal.pcbi.1011888, PubMed 38446830
Department of Molecular Cell Biology, Institute for Cancer Research The Norwegian Radium Hospital, Montebello, N-0379 Oslo, Norway Telephone +47 22 78 19 82 (Enserink), +47 22 78 12 69 (Dept. Secretary) Email: j.m.enserink@ibv.uio.no
